Literature DB >> 32051327

Role of Projections between Piriform Cortex and Orbitofrontal Cortex in Relapse to Fentanyl Seeking after Palatable Food Choice-Induced Voluntary Abstinence.

David J Reiner1,2, Olivia M Lofaro3, Sarah V Applebey3, Hannah Korah3, Marco Venniro3, Carlo Cifani3, Jennifer M Bossert3, Yavin Shaham1.   

Abstract

We recently developed a rat model of relapse to drug seeking after food choice-induced voluntary abstinence. Here, we used this model to study the role of the orbitofrontal cortex (OFC) and its afferent projections in relapse to fentanyl seeking. We trained male and female rats to self-administer palatable food pellets for 6 d (6 h/d) and intravenous fentanyl (2.5 μg/kg/infusion) for 12 d (6 h/d). We assessed relapse to fentanyl seeking after 13-14 voluntary abstinence days, achieved through a discrete choice procedure between fentanyl infusions and palatable food (20 trials/d). In both sexes, relapse after food choice-induced abstinence was associated with increased expression of the activity marker Fos in the OFC. Pharmacological inactivation of the OFC with muscimol plus baclofen (50 + 50 ng/side) decreased relapse to fentanyl seeking. We then determined projection-specific activation of OFC afferents during the relapse test by using Fos plus the retrograde tracer cholera toxin B (injected into the OFC). Relapse to fentanyl seeking was associated with increased Fos expression in the piriform cortex (Pir) neurons projecting to the OFC, but not in projections from the basolateral amygdala and thalamus. Pharmacological inactivation of the Pir with muscimol plus baclofen decreased relapse to fentanyl seeking after voluntary abstinence. Next, we used an anatomical disconnection procedure to determine whether projections between the Pir and OFC are critical for relapse to fentanyl seeking. Unilateral muscimol plus baclofen injections into the Pir in one hemisphere plus unilateral muscimol plus baclofen injections into the OFC in the contralateral, but not ipsilateral, hemisphere decreased relapse. Our results identify Pir-OFC projections as a new motivation-related pathway critical to relapse to opioid seeking after voluntary abstinence.SIGNIFICANCE STATEMENT There are few preclinical studies of fentanyl relapse, and these studies have used experimenter-imposed extinction or forced abstinence procedures. In humans, however, abstinence is often voluntary, with drug available in the drug environment but forgone in favor of nondrug alternative reinforcers. We recently developed a rat model of drug relapse after palatable food choice-induced voluntary abstinence. Here, we used classical pharmacology, immunohistochemistry, and retrograde tracing to demonstrate a critical role of the piriform and orbitofrontal cortices in relapse to opioid seeking after voluntary abstinence.
Copyright © 2020 the authors.

Entities:  

Keywords:  addiction; anterior insular cortex; disconnection; opioid; orbitofrontal cortex; self-administration

Year:  2020        PMID: 32051327      PMCID: PMC7083529          DOI: 10.1523/JNEUROSCI.2693-19.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  24 in total

1.  A Piriform-Orbitofrontal Cortex Pathway Drives Relapse to Fentanyl-Seeking after Voluntary Abstinence.

Authors:  Nicholas A Everett; Sarah J Baracz
Journal:  J Neurosci       Date:  2020-10-21       Impact factor: 6.167

2.  Characterization of operant social interaction in rats: effects of access duration, effort, peer familiarity, housing conditions, and choice between social interaction vs. food or remifentanil.

Authors:  Jonathan J Chow; Nicholas J Beacher; Jules M Chabot; Marvellous Oke; Marco Venniro; Da-Ting Lin; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2022-03-01       Impact factor: 4.530

Review 3.  Factors modulating the incubation of drug and non-drug craving and their clinical implications.

Authors:  Marco Venniro; Ingrid Reverte; Leslie A Ramsey; Kimberly M Papastrat; Ginevra D'Ottavio; Michele Stanislaw Milella; Xuan Li; Jeffrey W Grimm; Daniele Caprioli
Journal:  Neurosci Biobehav Rev       Date:  2021-09-28       Impact factor: 8.989

4.  Acute food deprivation-induced relapse to heroin seeking after short and long punishment-imposed abstinence in male rats.

Authors:  C Borges; F Inigo; N Quteishat; J Charles; E Ah-Yen; Shalev U
Journal:  Psychopharmacology (Berl)       Date:  2022-08-11       Impact factor: 4.415

5.  Individual differences in addiction-like behaviors and choice between cocaine versus food in Heterogeneous Stock rats.

Authors:  Sharona Sedighim; Lieselot Lg Carrette; Marco Venniro; Yavin Shaham; Giordano de Guglielmo; Olivier George
Journal:  Psychopharmacology (Berl)       Date:  2021-08-20       Impact factor: 4.415

6.  Insights into the Neurobiology of Craving in Opioid Use Disorder.

Authors:  Lindsay M Lueptow; Elizabeth C Shashkova; Margaret G Miller; Christopher J Evans; Catherine M Cahill
Journal:  Curr Anesthesiol Rep       Date:  2020-09-29

7.  The Neurotransmitter Receptor Architecture of the Mouse Olfactory System.

Authors:  Kimberley Lothmann; Katrin Amunts; Christina Herold
Journal:  Front Neuroanat       Date:  2021-04-23       Impact factor: 3.856

8.  Remifentanil self-administration in mice promotes sex-specific prefrontal cortex dysfunction underlying deficits in cognitive flexibility.

Authors:  Eden M Anderson; Annabel Engelhardt; Skyler Demis; Elissa Porath; Matthew C Hearing
Journal:  Neuropsychopharmacology       Date:  2021-05-19       Impact factor: 8.294

9.  Cell adhesion factors in the orbitofrontal cortex control cue-induced reinstatement of cocaine seeking and amygdala-dependent goal seeking.

Authors:  Alonzo J Whyte; Gracy Trinoskey-Rice; Rachel A Davies; Ellen P Woon; Stephanie L Foster; Lauren P Shapiro; Dan C Li; Kolluru D Srikanth; Hava Gil-Henn; Shannon L Gourley
Journal:  J Neurosci       Date:  2021-05-27       Impact factor: 6.167

Review 10.  Ethanol modulation of cortico-basolateral amygdala circuits: Neurophysiology and behavior.

Authors:  Brian A McCool
Journal:  Neuropharmacology       Date:  2021-08-08       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.